Aww bless...You are fookin hilarious. Maybe you should consider moving abroad?
Another of the cupid stunts repeats that same old duff record...
How often do you swap around that single brain cell?
Aww bless...You are fookin hilarious. Maybe you should consider moving abroad?
Apparently he did a year ago. Made the decision to leave but chose to stay though. Several excuses given, I’m sure there’ll be more to come. Watch this space.You are fookin hilarious. Maybe you should consider moving abroad?
Dopy analogyUK left the EU in the same way that Woody left home when he was 14.
He left, but continued living in the same house, sleeping in the same bedroom, paying housekeeping money from his Saturday job and having his dinner cooked by his mum. He had to be home by 10pm on school nights and wasn't allowed girls in his room. His dad still drive him to Scouts.
Some people say that's not "leaving home" but Woody says it is.
Aww blessApparently he did a year ago. Made the decision to leave but chose to stay though. Several excuses given, I’m sure there’ll be more to come. Watch this space.
Hmm. Someone else on here said they’d agreed to do something but didn’t. Now where would I get that idea from?Funny thing though is that he agreed to STFU on this 'issue',
Okay, I did say that but I was doing this at the time.
="ellal, post: 4813718, member: 9402"]Aww bless...
Another of the cupid stunts repeats that same old duff record...
How often do you swap around that single brain cell?
i think this may be a bit of a PR stunt by Hornsby....
Don't be silly. Obviously you do.Who cares? Not transam
Don't be silly. Obviously you do.
Why mention it otherwise?
Check out de Spiegels assessment of the German /EU lax approach to securing a vaccine, and the situation over there.because:
Most European Union countries are waiting for the EMA to grant approval. The EMA has said it will decide by 29 December whether to provisionally authorise the Pfizer and BioNTech vaccine. Unlike the UK’s temporary authorisation, the EMA is hoping to grant the vaccine “conditional marketing authorisation” for its use in any EU country.
The Swiss medical regulator Swissmedic has said it did not have all the data it needed to approve the vaccines, especially when it came to use in people with pre-existing illnesses. “We lack data on the effectiveness of the clinical trials and on the important subgroups that participated in these large studies,” said Claus Bolte, head of Swissmedic’s authorisation division, at a press briefing on 1 December.4